Local hyperthermia combined with cisplatin infusion treatment of malignant pleural pleural effusion.docVIP

 PAGE \* MERGEFORMAT 7 Local hyperthermia combined with cisplatin infusion treatment of malignant pleural pleural effusion Of: Cai Yu Peng Wang Jianguo Liu Yang Liu Wei Zhang Weipeng [Abstract] Objective To observe the intrapleural injection of local hyperthermia combined with cisplatin in the treatment of malignant pleural effusion clinical efficacy and side effects. Methods 54 patients with malignant pleural effusion were randomly divided into 2 groups, treatment group, 28 cases were treated with local hyperthermia combined with cisplatin chest perfusion in the control group, 26 cases of single thoracic infusion of cisplatin. Results and KPS score group was significantly improved compared with the control group (P lt;0.05. Conclusions local hyperthermia combined with cisplatin infusion can significantly improve the pleural malignant pleural effusion treatment. [Keywords:] malignant pleural effusion pleural infusion of local hyperthermia and cisplatin Malignant pleural effusion is a common complication in patients with advanced cancer, seriously affecting the quality of life. Our department since January 2008, the local high frequency hyperthermia combined with chest chest of drug infusion treatment of malignant pleural effusion, has been fairly satisfactory effect, are reported below. 1 Materials and Methods The clinical data of 1.1 in January 2008 in our department in February -2009 were treated 54 patients with malignant pleural effusion. 30 males and 24 females, aged 30-75 years, median age of 55 years. Including 28 cases of lung cancer, breast 10 cases of cancer, liver in 7 cases, 6 cases of colorectal cancer, 3 cases of gastric cancer cases were confirmed by pathology and .54 (or) cytologically proven malignant pleural effusion found in cancer cells. randomly divided into treatment and control groups, which Treatment of 28 cases, 26 patients in control group. KPS score were two groups of patientsgt; 50, blood examination was nor